- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Insider Buying
Global Pharmaceuticals & Biotech High Insider Buying
Results
199
34 new
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
199 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AZN | UK£99.69 | -1.7% | -1.2% | UK£154.5b | UK£140.72 | PE30.1x | E18.0% | 2.3% | ||
PFE New | US$24.94 | -6.7% | -17.7% | US$142.2b | US$32.55 | PE33.1x | E16.8% | 6.7% | ||
GSK | UK£13.00 | -4.6% | -7.9% | UK£53.0b | UK£18.55 | PE21.1x | E21.9% | 4.5% | ||
SMMT | US$18.62 | -4.4% | 854.9% | US$14.7b | US$34.27 | PB31.4x | S85.4% | n/a | ||
EXAS New | US$52.70 | 3.9% | -19.4% | US$10.0b | US$70.14 | PS3.6x | E72.6% | n/a | ||
1093 | HK$5.19 | 0% | -26.4% | HK$60.7b | HK$7.35 | PE10.9x | E2.7% | 6.2% | ||
BRKR New | US$53.37 | -4.6% | -18.0% | US$7.3b | US$74.74 | PE26.5x | E32.3% | 0.4% | ||
ELAN | US$13.44 | -5.3% | 12.7% | US$6.6b | US$17.84 | PE32.4x | E2.7% | n/a | ||
ABCM | US$23.99 | 0.08% | 54.7% | US$5.5b | US$23.66 | PE1758.5x | E39.3% | 0% | ||
BHVN | US$46.83 | -4.5% | 54.7% | US$4.7b | US$66.57 | PB15x | E21.6% | n/a | ||
002821 | CN¥88.50 | 3.2% | -37.5% | CN¥30.5b | CN¥94.33 | PE40.8x | E29.9% | 2.0% | ||
867 | HK$7.65 | -0.5% | -46.1% | HK$18.6b | HK$10.87 | PE12.4x | E21.4% | 5.5% | ||
NAMS | US$20.01 | -18.7% | 102.3% | US$2.2b | US$38.48 | PS55x | E28.5% | n/a | ||
1530 | HK$5.69 | -2.4% | -23.1% | HK$13.8b | HK$7.97 | PE7.5x | E14.6% | 4.3% | ||
CLDX New | US$26.40 | -1.6% | -4.9% | US$1.7b | US$67.10 | PS175.6x | E1.1% | n/a | ||
VRDN | US$19.79 | -12.0% | 26.2% | US$1.6b | US$40.63 | PS5190.8x | E32.1% | n/a | ||
6185 | HK$29.15 | -3.0% | 5.6% | HK$12.3b | HK$29.92 | PS9x | E141.4% | 0% | ||
2005 | HK$3.81 | -1.3% | -23.3% | HK$11.6b | HK$6.16 | PE8.3x | E5.8% | 4.7% | ||
BIOA B | SEK 178.10 | 17.6% | -24.5% | SEK 15.7b | SEK 320.80 | PS94.3x | E62.2% | 0% | ||
ALIF B | SEK 128.30 | -4.9% | 39.5% | SEK 15.6b | SEK 165.50 | PE133.6x | E52.0% | 0.4% | ||
GNS | UK£16.86 | -5.1% | -18.2% | UK£1.1b | UK£26.33 | PE140.2x | E37.7% | 1.9% | ||
TLRY New | US$1.29 | -10.4% | -27.9% | US$1.2b | US$2.20 | PS1.4x | E72.0% | n/a | ||
MRVI New | US$4.82 | -14.4% | -6.8% | US$1.2b | US$9.73 | PS2.5x | E84.7% | n/a | ||
MSB | AU$1.49 | -16.6% | 275.9% | AU$1.8b | AU$1.46 | PS186.7x | E61.5% | n/a |